Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:191-195
Published online before print December 11, 2003, doi: 10.1161/01.STR.0000107188.29688.2C
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/1/191    most recent
01.STR.0000107188.29688.2Cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winter, B.
Right arrow Articles by Endres, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winter, B.
Right arrow Articles by Endres, M.

(Stroke. 2004;35:191.)
© 2004 American Heart Association, Inc.


Original Contributions

Dysexecutive Syndrome After Mild Cerebral Ischemia?

Mice Learn Normally but Have Deficits in Strategy Switching

Benjamin Winter, MS; Bettina Bert, DVM; Heidrun Fink, MD; Ulrich Dirnagl, MD Matthias Endres, MD

From Klinik und Poliklinik für Neurologie, Charité, Humboldt-Universität zu Berlin (B.W., U.D., M.E.), and Institut für Pharmakologie und Toxikologie, Fachbereich Veterinärmedizin, Freie Universität (B.B., H.F.), Berlin, Germany.

Correspondence to Priv-Doz Dr Matthias Endres, Klinik und Poliklinik für Neurologie der Charité, Schumanstr 20/21, 10117 Berlin, Germany. E-mail Matthias.endres{at}charite.de


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background and Purpose— We determined long-term functional outcome in a well-characterized mouse model of mild focal cerebral ischemia.

Methods— We subjected 129/SV mice to sham operation or 30 minutes of left middle cerebral artery occlusion (MCAo) followed by reperfusion (89% survival rate). Six weeks later, animals were tested for neurological deficits, motor coordination on an accelerating Rota-rod apparatus, and spatial navigation in a water maze task. Brain lesion size was determined on NeuN-immunostained coronal brain sections by computer-assisted volumetry.

Results— Mice had mild but distinct neurological deficits and no deficits in Rota-rod coordination or swimming speed 6 weeks after MCAo. Moreover, mice had normal spatial learning abilities in the place task. However, stroke mice had deficits in the probe trial and visible platform task, which correlated with striatal lesion size determined on NeuN-immunostained sections.

Conclusions— After mild ischemia, mice recover with mild neurological deficits and normal motor coordination. Stroke mice have no obvious deficits in spatial learning in the Morris water maze but display distinct deficits related to strategy switching and relearning.


Key Words: animal models • behavior, animal • outcome • stroke, ischemic


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Stroke is still the most common cause of long-term disability in adulthood.1 In addition to a wide range of motor and sensory deficits, cognitive and behavioral abnormalities are observed after stroke, including in patients with caudate infarcts.2 However, most preclinical evaluations of outcome from stroke have used morphometric assessment of infarct volume. Although it is logical to assume that the volume of infarction will be closely correlated with outcome, impairment or preservation of complex behavior may reflect changes at a subcellular level or changes in synaptic or electrophysiologic function or may reflect diffuse morphological changes that are not quantified by counting dead neurons or drawing a cursor around a contiguous infarcted region.3 Several studies have reported the occurrence of cognitive deficits in experimental models of global and focal ischemia.4–6 However, data regarding transient ischemia—especially in the mouse—are scarce.

We have recently developed a model of mild focal brain ischemia in the mouse in which neuronal cell death evolves over days in the caudato-putamen while glial cells survive the insult (Figure 1).7, 8 Neuronal death exclusively affects medium spiny projection neurons, whereas all types of interneurons remain intact.9 Moreover, mortality is high in mouse models of severe ischemia, amounting to as much as 50% to 70% after 7 days,10–12 whereas survival rates in our mild model are {approx}90% at 6 weeks. This model may be ideally suited to study long-term sequelae after stroke.



View larger version (94K):
[in this window]
[in a new window]
 
Figure 1. 129/SV mice were exposed to 30 minutes of MCAo followed by reperfusion and killed 6 weeks later. NeuN immunohistochemistry (40-µm coronal brain section) demonstrates neuronal sparing confined to the caudato-putamen.

Therefore, in this study, we characterized long-term functional outcome after 30 minutes of left middle cerebral artery occlusion (MCAo) and reperfusion. We evaluated sensorimotor neurological deficits using a well-established rating scale first described by Bederson et al.13 Motor coordination was tested with a standardized Rota-rod apparatus, and swimming speed was determined in a swimming pool. Spatial learning was assessed in the Morris water maze task. In addition to a standard place task over 7 days, we performed a probe trial and visible platform task to assess strategy switching and relearning.14, 15


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Animals and Model of Cerebral Ischemia
All experimental procedures conformed to institutional and international guidelines. Male 129S6/SvEv wild-type mice (18 to 20 g) were housed in groups of 4 to 5 at 20°C to 21°C and standard light/dark cycle (8 AM to 8 PM). Mice were anesthetized with 1.0% isoflurane in 70% N2O and 30% O2 using a vaporizer and subjected to left filamentous 30-minute MCAo (n=9) or sham operation (n=8) with monitoring for regional cerebral blood flow and temperature as described.8 One animal died after MCA occlusion.

Neurological Deficits
After 6 weeks, mice were tested for neurological sensorimotor deficits and were scored by a blinded observer as described by Bederson et al,13 with the following minor modification as described: 0=no observable deficit (normal); 1=failure to extend the right forepaw (mild); 2=circling to the contralateral side (moderate); and 3=loss of walking or righting reflex (severe).

Spatial Navigation
Experiments were closely adapted from previously published protocols with minor modifications.14, 15 A 101-cm-diameter, 50-cm-high swimming pool with cues present at fixed positions was filled to a depth of 30 cm with 15°C opaque water. Temperature was controlled regularly, and water was exchanged once the temperature reached 16°C. A clear Plexiglas platform (11x11 cm=121 cm2) was submerged with the top located 1 cm below the surface. Swimming performance (eg, path, speed, latency, distance) was tracked with a computer-based system (TSE Systems). A full experiment consisted of a place task (learning period) with 3 trials per day for 7 consecutive days, a probe trial (spatial probe) on day 8, and a visible platform test (reverse learning with visual cues) on day 9 as described.14, 15 For the place task, which is a test for nonspatial and spatial learning, the platform was always located in the center of the same quadrant (ie, target quadrant) for an animal. Each trial consisted of maximally 90 seconds starting from 1 of the 3 remaining quadrants with the face of the animal facing the wall. If after 90 seconds an animal did not reach the platform, it was guided to the platform. After reaching the platform, animals were allowed to remain there for 30 seconds. The intertrial interval was 1 minute, and mice were quickly dried with a towel and put under a heating lamp at exactly 37°C between each trial to avoid hypothermia. In the place task, the latencies, path lengths, and swim speeds for a single day were averaged to a come up with a daily mean. For the probe trial, the platform was removed, and mice were allowed to swim for 90 seconds. Trials were analyzed by preference analysis (for the target quadrant and zone) with this formula: [(T-A)+(T-B)+(T-C)]/3, where T is the swim time in the target quadrant (or zone) and A, B, and C are swim times in the remaining 3 quadrants (or zones). In the visible platform task, a clearly visible platform was re-placed into the swimming pool but opposite the previous target quadrant. This task consisted of 3 trials starting from different quadrants with an intertrial interval of 1 minute.

Motor Coordination
Motor coordination was tested using an accelerating Rota-rod treadmill for mice (TSE Systems; 3-cm diameter) 1 day after the Morris water maze experiment was finished. After familiarization with the Rota-rod at a constant speed of 4 rpm (3 runs of 120 seconds each with an intertrial interval of 2 hours), the actual test was performed on the next day. The mice were placed on the rotating drum with an accelerating speed from 4 to 40 rpm. Maximum speed was reached after 245 seconds, and maximum testing time was 300 seconds. The time spent on the drum was registered automatically (time until drop in seconds).

Lesion Determination
At the end of the experiments, animals were deeply anesthetized and perfused transcardially with 4% paraformaldehyde in 0.1 mol/L phosphate-buffered saline. Brains were carefully removed and postfixed in the same fixative overnight at 4°C. Coronal 40-µm sections were cut on a Vibratome (Technical Products). For NeuN immunohistochemistry, the sections were first incubated in a blocking solution containing 10% normal goat serum and 0.1% Triton X-100 in phosphate-buffered saline and then incubated overnight at 4°C with anti-NeuN antibodies (mouse monoclonal, 1:100; Chemicon) and a 3-stage avidin-biotin method with corresponding biotinylated secondary antibody.8 The reaction product was visualized with 3', 3'-diaminobenzidine as chromogene. NeuN-negative lesion volume was quantified with a computerized image analysis system (Sigma Scan Pro 4.0, Jandel Scientific) and calculated by summing the lesion areas of each section directly.7

Statistical Analysis
Data are presented as mean±SEM. Comparisons were made by 2-way repeated-measures ANOVA, followed by Tukey’s posthoc test (water maze), the Mann-Whitney rank-sum test (neurological deficit score), and Student’s t test (Rota-rod) or Pearson’s correlation. A value of P<0.05 was considered statistically significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
All mice subjected to MCAo ("stroke") exhibited neurological deficit scores of >=2 30 minutes after reperfusion, whereas all sham-operated mice had a score of 0. At 6 weeks, stroke animals still had distinct deficits (typically a mild forepaw palsy but no circling behavior) with a median score of 1.0 (0.50 and 1.0 for 25% and 75% confidence intervals) versus 0.0 (0.0 for 25% and 75% confidence intervals) in sham animals (P=0.01, Mann-Whitney rank-sum test). Motor coordination on Rota-rod was not different between groups at 6 weeks (time until drop, 200±27 versus 189±23 seconds for stroke versus sham animals, respectively; P>0.05).

For assessment of spatial learning, we exposed animals to a Morris water maze task. In the place task (Figure 2), we found that animals in both the sham and stroke groups showed a rapid decrease in latency and path length to find the platform, so that by day 5 they were performing near an asymptotic level of accuracy. Two-way repeated-measures ANOVA showed a significant effect of trial day on latency (F(6,84)=11.357; P<0.05) but no differences between sham and stroke mice (group, F(1,14)=0.0543; P=0.80) and no significant group-by-trial interaction (F(6,84)=1.137; P=0.35). Analysis for path length yielded similar results (see Figure 2B). Swimming speed varied slightly over time during the place task; however, there were no differences in swimming speed between sham and stroke mice (Figure 2C). Together, these data indicate that stroke mice have no deficit in spatial learning compared with sham controls.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 2. Latencies (A), path lengths (B), and swimming speed (C) in stroke and sham animals on a place task in a swimming pool. Mean±SEM (average of tree trials per day); n=8 per group. For statistical analysis, see text.

On day 8, animals were tested in a probe trial in which the platform is removed and animals are allowed to swim for 90 seconds (Figure 3). As in the place task, swimming speed was not different between sham and stroke animals (18.4±2.7 versus 17.9±1.3 cm/s). We noticed that sham animals spent less time in the target zone in the last minute of the trial (ie, from 31 to 90 seconds). In contrast, stroke animals had a higher preference for the target zone over time (see selected swim paths in Figure 3A). Two-way repeated-measures ANOVA revealed a statistically significant interaction between time (ie, intervals of 0 to 30, 31 to 60, and 61 to 90 seconds) and group (stroke or sham) for the number of target crossings (F(2,24)=3.874; P<0.05) and similarly time spent in the target zone (F(2,24)=3.937; P<0.05). Posthoc analysis (Tukey’s test) revealed that sham mice but not stroke mice had significant differences over time (P<0.05 for 61 to 90 seconds versus 0 to 30 seconds; Figure 3). Moreover, there was a significant effect of time (F(2,24)=3.987; P<0.05) and a time-by-group interaction for target zone preference (F(2,24)=4.372; P<0.05). Tukey’s posthoc testing revealed significant differences between stroke and sham animals during the 31- to 60-second interval (P<0.05) and the 61- to 90-second interval (P<0.05; Figure 3B).



View larger version (51K):
[in this window]
[in a new window]
 
Figure 3. A, Swim patterns of selected animals (T=target zone) and number of target crossings in probe trial (day 8); *P<0.05 vs 0- to 30-second interval. B, Time in target zone and nontarget zones and target zone preference; *P<0.05 vs 0- to 30-second interval; #P<0.05 vs stroke group and 0- to 30-second interval. C, Time in target quadrant and nontarget quadrants and target quadrant preference. Mean±SEM; n=8 per group; 2-way repeated-measures ANOVA and Tukey’s post-hoc test.

In the last part of the water maze (ie, day 9), we performed a visible platform task in which a visible platform is placed in the quadrant opposite the former target quadrant (Figure 4). In this trial, animals typically revisit the target zone learned in the first trial, but they quickly find the visible platform in the second and third trials (see swim patterns in Figure 4A). Two-way repeated-measures ANOVA revealed a significant effect of trial on latency (F(2,24)=4.581; P<0.05; Figure 4B). Posthoc testing, however, demonstrated a significant effect of trial only in the sham group (P<0.05 for trial 1 versus 3). Indeed, in the stroke group, brain lesion volume significantly correlated with latencies in trials 2 and 3 (Figure 4B). Average brain lesion volume on NeuN-immunostained sections was 9.7±1.1 mm3 and confined to the caudato-putamen in the stroke group (Figure 1).



View larger version (43K):
[in this window]
[in a new window]
 
Figure 4. A, Swim patterns of selected animals (T=target zone; black square is visible platform) in 3 trials of a visible platform task (day 9). B, Latencies (mean±SEM) to find the platform in stroke and sham mice; *P<0.05 vs trial 1. Latencies in trials 2 and 3 correlated with brain lesion size determined on NeuN-immunostained sections in stroke mice (Pearson’s correlation). C, Time spent in the former target quadrant (mean±SEM) in stroke and sham mice over 3 trials; *P<0.05 vs trial 1. Time spent in the former target quadrant (trial 2) significantly correlated with brain lesion size determined on NeuN-immunostained sections in stroke mice; Pearson’s correlation; n=8 per group.

We found that, in contrast to sham animals, several stroke animals revisited the formerly learned target in trials 2 and 3 of the task (see swim pattern video records in Figure 4A). The time that mice spent in the quadrant that had previously contained the platform varied as a function of trial (F(2,24)=5.133; P<0.05; Figure 4C); however, posthoc testing revealed significant differences between trials in the sham group (P<0.05 compared with trial 1; Figure 4C) but not the stroke group. In the stroke mice, brain lesion volume significantly correlated with time spent in the former target quadrant (trial 2; Figure 4C).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
Here, we characterized long-term functional outcome after mild focal brain ischemia in the 129/SV mouse. Interestingly, motor coordination on a Rota-rod was not affected by cerebral ischemia, and stroke mice displayed only mild sensorimotor neurological deficits at 6 weeks. Moreover, we demonstrate that, at 6 weeks after mild brain ischemia, mice have no apparent deficits in spatial learning in the Morris water maze: stroke mice had similar latencies and path lengths to find the platform in a standard place task over 7 days compared with sham controls (Figure 2).

However, stroke mice displayed distinct deficits in the probe trial and visible platform task. Although in the first 30 seconds of the probe trial stroke mice spent as much time in the presumed target as sham controls, they did not switch strategies afterward and explored the remaining quadrants of the swimming pool in the last minute of the trial (Figure 3). In the visible platform task (relearning with visible cues), stroke mice in contrast to sham mice tended to revisit the former target zone in trials 2 and 3 (Figure 4). Brain lesion areas determined on NeuN-immunostained sections reflecting neuronal loss were confined to the caudato-putamen of the left hemisphere as predicted from previous studies (Figure 1). 8–10 Importantly, lesion size of individual animals significantly correlated with latencies in trials 2 and 3 and with time spent in the former target quadrant in the visible platform task (Figure 4). This finding indicates that animals with larger lesions tend to revisit the formerly learned target and to have longer latencies to find the new platform. We identified distinct deficits in strategy switching and relearning after mild cerebral ischemia in the mouse. Although learning and memory seem to be unaffected, the observed impairment in behavioral flexibility partially resembles the dysexecutive syndrome observed in patients with basal ganglia disorders (eg, deficits in mental and motor switching).16

There are some caveats with regard to our data. Neurological sensorimotor deficits and changes in visual acuity may affect performance during spatial navigation. However, we performed the water maze experiments 6 weeks after surgery, when residual deficits were mild and when MCAo had no effects on motor coordination as determined on a Rota-rod. Notably, in contrast to rats, mice use their tails for swimming, and swimming speeds in the stroke mice were not different from those in controls (Figure 2). The fact that stroke mice had equal latencies and path lengths in the place task (which depends on visual cues) implies that any changes in visual acuity in the stroke mice would not have an impact on performance in the water maze task.

It has previously been reported for rats that caudato-putamen lesions may affect acquisition, retention, and selection of spatial navigation strategies.17 In addition, several authors have detected disturbances of memory acquisition and learning after MCAo in rats using avoidance tasks and maze tasks.18–22 Of interest, using passive avoidance test and transfer latency in the elevated-plus maze, Gupta and coworkers6 detected normal learning and memory in rats subjected to transient focal ischemia.

So far, evidence is lacking that insight gained from animal models of cerebral ischemia is of any relevance to the pathophysiology of stroke in humans. None of the neuroprotective strategies developed in rodent models proved effective in clinical trials. Of note, long-term stroke survival is woeful in the mouse stroke models, with mortality rates often >50% after 24 to 72 hours and functional outcome rarely tested at late time points.10–23 In contrast, in our model, survival rates are 90% at 6 weeks. Therefore, our model may be better suited for the study of long-term functional outcome as suggested by the Stroke Academic Industry Roundtable as the gold standard for preclinical neuroprotective and restorative drug development.23 It remains to be determined, however, whether the distinct dysexecutive deficits reported in this study are amenable to treatment.


*    Acknowledgments
 
This research was supported by the Deutsche Forschungsgemeinschaft (En343/7 Heisenberg-Program, Dr Endres) and the Hermann and Lilly Schilling Stiftung (Drs Endres and Dirnagl). We thank Ute Kopp and Juri Katchanov for critical discussion.

Received April 28, 2003; revision received August 29, 2003; accepted September 30, 2003.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 

  1. 2001 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2001.
  2. Caplan LR, Schmahmann JD, Kase CS, Feldmann E, Baquis G, Greenberg JP, Gorelick PB, Helgason C, Hier DB. Caudate infarcts. Arch Neurol. 1990; 47: 133–143.[Abstract]
  3. Aronowski J. Samways E, Strong R, Rhoades HM, Grotta JC. An alternative method for the quantitation of neuronal damage after experimental middle cerebral artery occlusion in rats: analysis of behavioral deficit. J Cereb Blood Flow Metab. 1996; 16: 706–713.
  4. Hirakawa M, Tamura A, Nagashima H, Nakayama H, Sano K. Disturbance of retention of memory after focal cerebral ischemia in rats. Stroke. 1994; 25: 2471–2475.[Abstract]
  5. Yonemori F, Yamada H, Yamaguchi T, Uemura A, Tamura. Spatial memory disturbance after focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1996; 16: 973–980.[CrossRef][Medline] [Order article via Infotrieve]
  6. Gupta YK, Sinha K, Chaudhary G. Transient focal ischemia induces motor deficit but does not impair the cognitive function in middle cerebral artery occlusion model of stroke in rats. J Neurol Sci. 2002; 203: 267–271.[Medline] [Order article via Infotrieve]
  7. Endres M, Namura S, Shimizu-Sasamata M, Waeber C, Zhang L, Gomez-Isla T, Hyman BT, Moskowitz MA. Attenuation of delayed neuronal cell death after mild focal ischemia by inhibitors of the caspase family. J Cereb Blood Flow Metab. 1998; 81: 238–247.
  8. Katchanov J, Harms C, Gertz K, Hauck L, Waeber C, Hirt L, Priller J, von Harsdorf R, Brück W, Hörtnagl H, Dirnagl U, Bhide PG, Endres M. Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death. J Neurosci. 2001; 21: 5045–5053.[Abstract/Free Full Text]
  9. Katchanov J, Waeber C, Gertz K, Gietz A, Winter B, Brück W, Dirnagl U, Veh RW, Endres M. Selective neuronal vulnerability following mild focal brain ischemia in the mouse. Brain Pathol. 2003; 13: 452–464.[Medline] [Order article via Infotrieve]
  10. Prass K, Meisel C, Höflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov I, Priller J, Dirnagl U, Volk HD, Meisel A. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation: reversal by post-stroke Th1-like immunostimulation. J Exp Med. 2003.Published ahead of print DOI: 10.1094/jem. 20021098.
  11. Kondo T, Reaume AG, Huang TT, Carlson E, Murakami K, Chen SF, Hoffman EK, Scott RW, Epstein CJ, Chan PH. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient cerebral ischemia. J Neurosci. 1997; 17: 4180–4189.[Abstract/Free Full Text]
  12. Huang J, Agus DB, Winfree CJ, Kiss W, Mack WJ, McTaggert RA, Choudhrie TF, Kim LJ, Mocco J, Pinsky DJ, et al. Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc Natl Acad Sci U S A. 2001; 98: 11720–11724.[Abstract/Free Full Text]
  13. Bederson JB, Pitts LH, Tsuji M, Nishimuira MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986; 17: 472–476.[Abstract/Free Full Text]
  14. Bert B, Fink H, Huston JP, Voits M. Fischer 344 and Wistar rats differ in anxiety and habituation but not in water maze performance. Neurobiol Learning Memory. 2002; 78: 11–22.[CrossRef][Medline] [Order article via Infotrieve]
  15. Harker KT, Whisaw IQ. Impaired spatial performance in rats with retrosplenial lesions: importance of the spatial problem and the rat strain in identifying lesion effects in a swimming pool. J Neurosci. 2002; 22: 1155–1165.[Abstract/Free Full Text]
  16. Inzelberg R, Plotnik M, Flash T, Schechtman E, Shahar I, Korcyn AD. Mental and motor switching in Parkinson’s disease. J Mot Behav. 2001; 33: 377–385.[Medline] [Order article via Infotrieve]
  17. Whishaw IQ, Mittleman G, Bunsch ST, Dunnet SB. Impairments in the acquisition, retention and selection of spatial navigation strategies after medial caudate-putamen lesions in rats. Behav Brain Res. 1987; 24: 125–138.[CrossRef][Medline] [Order article via Infotrieve]
  18. Yamamoto F, Tamura A, Kirino T, Shimizu M, Sano K. Effects of a new thyrotropin releasing hormone derivative on behavioral changes after focal cerebral ischemia in rats. Stroke. 1989; 20: 362–366.[Abstract/Free Full Text]
  19. Markgraf CG, Green EJ, Hurwitz BE, Morikawa E, Dietrich WD, McCabe PM, Ginsberg MD, Schneiderman N. Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats. Brain Res. 1995; 575: 238–246.
  20. Okada M, Nakanishi H, Tamura A, Arae A, Mine K, Yamamoto K, Fujiwara M. Long-term spatial cognitive impairment after middle cerebral artery occlusion in rats: no involvement of the hippocampus. J Cereb Blood Flow Metab. 1995; 15: 1012–1021.[Medline] [Order article via Infotrieve]
  21. Okada M, Tamura A, Arae A, Nakagomi T, Kirino T, Mine K, Fujiwara M. Long-term spatial cognitive impairment following middle cerebral artery occlusion in rats: a behavioral study. J Cereb Blood Flow Metab. 1995; 15: 505–512.[Medline] [Order article via Infotrieve]
  22. Whal F, Allix M, Plotkine M, Boulu RG. Neurological and behavioral outcomes of focal cerebral ischemia in rats. Stroke. 1992; 23: 267–272.[Abstract/Free Full Text]
  23. Stroke Therapy Academic Industry Roundtable (STAIR). Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999; 30: 2752–2758.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Neurosci.Home page
G. Kronenberg, C. Harms, R. W. Sobol, F. Cardozo-Pelaez, H. Linhart, B. Winter, M. Balkaya, K. Gertz, S. B. Gay, D. Cox, et al.
Folate Deficiency Induces Neurodegeneration and Brain Dysfunction in Mice Lacking Uracil DNA Glycosylase
J. Neurosci., July 9, 2008; 28(28): 7219 - 7230.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. C. Steele Jr, Q. Guo, and S. Namura
Filamentous Middle Cerebral Artery Occlusion Causes Ischemic Damage to the Retina in Mice
Stroke, July 1, 2008; 39(7): 2099 - 2104.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Gertz, J. Priller, G. Kronenberg, K. B. Fink, B. Winter, H. Schrock, S. Ji, M. Milosevic, C. Harms, M. Bohm, et al.
Physical Activity Improves Long-Term Stroke Outcome via Endothelial Nitric Oxide Synthase-Dependent Augmentation of Neovascularization and Cerebral Blood Flow
Circ. Res., November 10, 2006; 99(10): 1132 - 1140.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. B. Tatro
Melanocortins Defend their Territory: Multifaceted Neuroprotection in Cerebral Ischemia.
Endocrinology, March 1, 2006; 147(3): 1122 - 1125.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/1/191    most recent
01.STR.0000107188.29688.2Cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winter, B.
Right arrow Articles by Endres, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winter, B.
Right arrow Articles by Endres, M.